文献速递血栓与止血贫血与红细胞疾病

血管性血友病因子抗原水平≤50 IU/dL的遗传学研究识别与血管性血友病及出血风险增加相关的变异

Genetic study of von Willebrand factor antigen levels ≤ 50 IU/dL identifies variants associated with increased risk of von Willebrand disease and bleeding.
PubMed 文献 · J Thromb Haemost · 2025-05-12

在Trans-Omics for Precision Medicine项目的7项研究中,对926例血管性血友病因子抗原(VWF:Ag)≤50 IU/dL病例和12846例对照进行全基因组关联研究,在ABO和VWF位点发现显著关联。VWF位点索引变异p.Tyr1584Cys(罕见,频率0.22%)的OR为78.58,ABO位点常见内含子变异OR为2.52;两变异也与确诊血管性血友病相关(VWF OR=7.16,ABO OR=1.57)。p.Tyr1584Cys杂合子中VWF:Ag≤50 IU/dL的外显率为24.2%,确诊血管性血友病外显率为0.3%。

要点

  • VWF:Ag≤50 IU/dL与ABO和VWF位点变异显著关联(P<5×10⁻⁹)。
  • p.Tyr1584Cys罕见变异OR=78.58,ABO常见变异OR=2.52。
  • p.Tyr1584Cys杂合子中VWF:Ag≤50 IU/dL外显率24.2%,确诊VWD外显率0.3%。

核心结论

  • 尽管目前对p.Tyr1584Cys致病性解释存在矛盾,结果提示其为低外显率致病性变异, contributing to VWF:Ag≤50 IU/dL、出血和血管性血友病。

研究设计与样本

  • 全基因组关联研究纳入Trans-Omics for Precision Medicine项目7项研究的926例VWF:Ag≤50 IU/dL病例和12846例对照。
  • 在5个生物库的708例血管性血友病病例和1286069例对照中检验显著全基因组发现与临床诊断血管性血友病的关联,并在FinnGen中检验与6种出血和血栓性疾病的关联。

主要发现

  • ABO和VWF两个位点变异与VWF:Ag≤50 IU/dL关联(P<5×10⁻⁹)。
  • VWF索引变异p.Tyr1584Cys为罕见(0.22%)错义变异,OR=78.58;ABO索引变异为常见内含子变异,效应较小(OR=2.52)。
  • VWF(OR=7.16)和ABO(OR=1.57)变异也与确诊血管性血友病相关(P<0.025)。
  • p.Tyr1584Cys杂合子中VWF:Ag≤50 IU/dL外显率为24.2%,确诊血管性血友病外显率为0.3%。
  • p.Tyr1584Cys与月经过多(OR=1.27)、缺铁性贫血(OR=1.55)和产时出血(OR=2.20)风险增加相关(P<0.0042),与深静脉血栓风险降低相关(OR=0.54)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: von Willebrand disease (VWD) is a common inherited bleeding disorder caused by low levels or activity of circulating von Willebrand factor (VWF). Genetic susceptibility to VWF antigen (VWF:Ag) below normal (≤ 50 IU/dL) in the general population is underexplored. OBJECTIVES: To identify genetic variants influencing VWF:Ag levels ≤ 50 IU/dL. METHODS: We performed a genome-wide association study in 926 cases with VWF:Ag levels ≤ 50 IU/dL and 12 846 controls from 7 studies from the Trans-Omics for Precision Medicine program. We then examined whether significant genome-wide findings were also associated with clinical diagnosis of VWD in 5 biobanks with 708 VWD cases and 1 286 069 controls, and with 6 bleeding and thrombotic disorders in FinnGen. RESULTS: Variants at 2 loci were associated (P < 5 × 10-9) with VWF:Ag levels ≤ 50 IU/dL: ABO and VWF. The VWF index variant, p.Tyr1584Cys, is a rare (0.22%) missense variant with odds ratio (OR) of 78.58, while the ABO index variant is a common intronic variant with a smaller effect (OR = 2.52). Notably, both VWF (OR = 7.16) and ABO (OR = 1.57) variants were also associated (P < .025) with diagnosed VWD. Among p.Tyr1584Cys heterozygotes, the penetrance of VWF:Ag levels ≤ 50 IU/dL was 24.2% and the penetrance of diagnosed VWD was 0.3%. p.Tyr1584Cys was associated (P < .0042) with increased odds of heavy menstrual bleeding (OR = 1.27), iron deficiency anemia (OR = 1.55), and intrapartum hemorrhage (OR = 2.20), but decreased odds of deep vein thrombosis (OR = 0.54). CONCLUSIONS: Although there are currently conflicting interpretations of pathogenicity p.Tyr1584Cys, our results suggest that it is a low penetrance pathogenic variant that contributes to VWF:Ag levels ≤ 50 IU/dL, bleeding, and VWD.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Friedman RK, Heath AS, Huffman JE, et al. Genetic study of von Willebrand factor antigen levels ≤ 50 IU/dL identifies variants associated with increased risk of von Willebrand disease and bleeding. J Thromb Haemost. 2025. PMID: 40368142. doi:10.1016/j.jtha.2025.04.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。